Literature DB >> 23120117

Intratympanic dexamethasone application in Meniere's disease-Is it superior to conventional therapy?

Gilbert Paragache1, Naresh K Panda, Meena Ragunathan.   

Abstract

OBJECTIVE: To compare the efficacy of conventional medical treatment versus transtympanic dexamethasone application into middle ear as treatment modality in Meniere's disease. STUDY
DESIGN: Prospective randomized study.
SETTING: Tertiary referral centre.
METHOD: Forty patients of Meniere's disease were treated, 20 by conventional method and 20 by transtympanic dexamethasone applications. INTERVENTION: Theraputic.
RESULTS: Vertigo control of 85% achieved in study group when compared to 80% in control group, 15% of patients had hearing improvement in study group while 10% had hearing improvement in control group. Aural fullness and tinnitus control were identical in both groups.
CONCLUSIONS: Both modalities of therapy were found to have almost equal efficacy, with Intra tympanic steroid (ITS) therapy having an edge over conventional therapy in cases with severe attacks and shorter duration of symptoms.

Entities:  

Keywords:  Dexamethasone; Intra tympanic steroid; Meniere's disease

Year:  2005        PMID: 23120117      PMCID: PMC3451534          DOI: 10.1007/BF02907620

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  14 in total

1.  Treatment of vestibular disorders.

Authors:  A Itoh; E Sakata
Journal:  Acta Otolaryngol Suppl       Date:  1991

Review 2.  Pharmacological treatment of vertigo.

Authors:  I Pyykkö; M Magnusson; L Schalén; H Enbom
Journal:  Acta Otolaryngol Suppl       Date:  1988

3.  Perspectives on the pharmacotherapy of vertigo.

Authors:  D S Zee
Journal:  Arch Otolaryngol       Date:  1985-09

4.  Immunological approach to Ménière's disease: vestibular immune injury following immune reaction of the endolymphatic sac.

Authors:  S Tomiyama; M Nonaka; Y Gotoh; T Ikezono; T Yagi
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1994       Impact factor: 1.538

5.  Treatment of acute vestibular vertigo.

Authors:  E Aantaa
Journal:  Acta Otolaryngol Suppl       Date:  1991

Review 6.  Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.

Authors:  J J Shea; X Ge
Journal:  Otolaryngol Clin North Am       Date:  1996-04       Impact factor: 3.346

7.  Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease.

Authors:  L Sennaroglu; G Sennaroglu; B Gursel; F M Dini
Journal:  Otolaryngol Head Neck Surg       Date:  2001-11       Impact factor: 3.497

8.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

9.  Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines.

Authors:  P M Santos; R A Hall; J M Snyder; L F Hughes; R A Dobie
Journal:  Otolaryngol Head Neck Surg       Date:  1993-10       Impact factor: 3.497

10.  Hearing results of intratympanic steroid treatment of endolymphatic hydrops.

Authors:  M A Arriaga; S Goldman
Journal:  Laryngoscope       Date:  1998-11       Impact factor: 3.325

View more
  3 in total

Review 1.  Intratympanic corticosteroids injections: a systematic review of literature.

Authors:  Philippe Lavigne; François Lavigne; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-23       Impact factor: 2.503

2.  Intratympanic (IT) Therapies for Menière's Disease: Some Consensus Among the Confusion.

Authors:  Desi P Schoo; Grace X Tan; Matthew R Ehrenburg; Seth E Pross; Bryan K Ward; John P Carey
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-05-03

Review 3.  Intratympanic corticosteroids in Ménière's disease: A mini-review.

Authors:  Mitesh Patel
Journal:  J Otol       Date:  2017-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.